← All indications
Pure Autonomic Failure
A degenerative disease of the AUTONOMIC NERVOUS SYSTEM that is characterized by idiopathic ORTHOSTATIC HYPOTENSION and a greatly reduced level of CATECHOLAMINES. No other neurological deficits are present.
Drugs by status
Phase 3 trials (2)
Phase 2 trials (1)
Phase 1 trials (31)
- acetazolamide
- bovril
- captopril
- diphenhydramine
- methylphenidate
- ibuprofen
- bq-123
- entacapone
- fluorodopa
- acarbose
- levodopa
- carbidopa
- octreotide
- indomethacin
- caffeine
- rivastigmine
- celecoxib
- angiotensin 1-7
- tranylcypromine
- trimethaphan
- losartan
- atomoxetine
- pyridostigmine bromide
- modafinil
- sodium chloride
- yohimbine
- ergotamine
- pseudoephedrine
- oxymetazoline
- ranitidine
- +1 more
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (1)